Consuming fat before carbohydrates reduces post-meal blood glucose
In treating diabetes, post-meal elevation of glucose levels is an important therapeutic target. Existing clinical studies indicate that…
Tirzepatide cuts fat mass by 35% while preserving skeletal muscle
Six months of real-world treatment reveals how weight, fat mass, skeletal muscle, and metabolic health change in adults…
A New King of The GLP-1s Could Be Crowned – Cardiac Wire
A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Experts call for safer weight loss as concerns grow over GLP-1 use
Japanese cases of ketosis and ketoacidosis are prompting a closer look at how GLP-1 medications, restrictive dieting, and…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
People judge weight loss more harshly when GLP-1 drugs are involved, study finds
Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…